These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 36521376)

  • 1. Therapeutic effect of ibrutinib, a selective Bruton's tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves' orbitopathy.
    Park HY; Chae MK; Ko J; Kikkawa DO; Jang SY; Yoon JS
    PLoS One; 2022; 17(12):e0279060. PubMed ID: 36521376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase C-γ as a Potential Therapeutic Target for Graves' Orbitopathy.
    Roh TH; Chae MK; Ko JS; Kikkawa DO; Jang SY; Yoon JS
    Endocrinol Metab (Seoul); 2023 Dec; 38(6):739-749. PubMed ID: 37989267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-derived growth factor-BB: a stimulus for cytokine production by orbital fibroblasts in Graves' ophthalmopathy.
    van Steensel L; Paridaens D; Dingjan GM; van Daele PL; van Hagen PM; Kuijpers RW; van den Bosch WA; Drexhage HA; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1002-7. PubMed ID: 19797221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of miR-146a in the Regulation of Inflammation in an In Vitro Model of Graves' Orbitopathy.
    Jang SY; Chae MK; Lee JH; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4027-34. PubMed ID: 27494344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Proprotein Convertase Subtilisin/Kexin Type 9 in the Pathogenesis of Graves' Orbitopathy in Orbital Fibroblasts.
    Lee GE; Kim J; Lee JS; Ko J; Lee EJ; Yoon JS
    Front Endocrinol (Lausanne); 2020; 11():607144. PubMed ID: 33488522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Mobility Group Box 1 Is Associated with the Inflammatory Pathogenesis of Graves' Orbitopathy.
    Han SY; Choi SH; Shin JS; Lee EJ; Han SH; Yoon JS
    Thyroid; 2019 Jun; 29(6):868-878. PubMed ID: 30973094
    [No Abstract]   [Full Text] [Related]  

  • 7. The Role of Adipsin, Complement Factor D, in the Pathogenesis of Graves' Orbitopathy.
    Byeon HJ; Chae MK; Ko J; Lee EJ; Kikkawa DO; Jang SY; Yoon JS
    Invest Ophthalmol Vis Sci; 2023 Aug; 64(11):13. PubMed ID: 37555734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect of selective interleukin-2-inducible tyrosine kinase inhibitor in orbital fibroblasts from patients with Graves' orbitopathy.
    Yoon Y; Park HY; Chae MK; Jang SY; Yoon JS
    Endocr J; 2024 Jun; ():. PubMed ID: 38866492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan inhibits inflammation and adipogenesis of orbital fibroblasts in Graves ophthalmopathy.
    Xiong H; Wu M; Zou H; Jiang S; Yi H; Yi T; Wang Q; Liu D; Zhou Y; Wei C; Zhou X
    Mol Vis; 2018; 24():509-517. PubMed ID: 30090014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen Synthase Kinase-3β Mediates Proinflammatory Cytokine Secretion and Adipogenesis in Orbital Fibroblasts from Patients with Graves' Orbitopathy.
    Lee JS; Chae MK; Kikkawa DO; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2020 Jul; 61(8):51. PubMed ID: 32735324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory Effect of Idelalisib, a Selective Phosphatidylinositol 3-Kinase δ Inhibitor, on Adipogenesis in an In Vitro Model of Graves' Orbitopathy.
    Ko J; Kim JY; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2018 Sep; 59(11):4477-4485. PubMed ID: 30193323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of intercellular adhesion molecule-1 induced by CD40-CD40L ligand signaling in orbital fibroblasts in patients with Graves' ophthalmopathy.
    Zhao LQ; Wei RL; Cheng JW; Cai JP; Li Y
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4652-60. PubMed ID: 20107176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of tanshinone IIA in an in vitro model of Graves' orbitopathy.
    Rhiu S; Chae MK; Lee EJ; Lee JB; Yoon JS
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5900-10. PubMed ID: 25159204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tea Polyphenols Reduce Inflammation of Orbital Fibroblasts in Graves' Ophthalmopathy via the NF-κB/NLRP3 Pathway.
    Liu W; Ma C; Li HY; Yuan SS; Li KJ
    Curr Med Sci; 2023 Feb; 43(1):123-129. PubMed ID: 36821039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-155 acts as an anti-inflammatory factor in orbital fibroblasts from Graves' orbitopathy by repressing interleukin-2-inducible T-cell kinase.
    Choi YJ; Kim C; Choi EW; Lee SH; Chae MK; Jun HO; Kim BY; Yoon JS; Jang SY
    PLoS One; 2022; 17(8):e0270416. PubMed ID: 35980936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein tyrosine phosphatase 1B as a therapeutic target for Graves' orbitopathy in an in vitro model.
    Byeon HJ; Kim JY; Ko J; Lee EJ; Don K; Yoon JS
    PLoS One; 2020; 15(8):e0237015. PubMed ID: 32760098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pirfenidone attenuates IL-1β-induced COX-2 and PGE2 production in orbital fibroblasts through suppression of NF-κB activity.
    Choi YH; Back KO; Kim HJ; Lee SY; Kook KH
    Exp Eye Res; 2013 Aug; 113():1-8. PubMed ID: 23664858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Effect of Curcumin, a Plant Polyphenol Extracted From Curcuma longae, in Fibroblasts From Patients With Graves' Orbitopathy.
    Lee JS; Kim J; Lee EJ; Yoon JS
    Invest Ophthalmol Vis Sci; 2019 Oct; 60(13):4129-4140. PubMed ID: 31593984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves' Orbitopathy.
    Han YE; Hwang S; Kim JH; Byun JW; Yoon JS; Lee EJ
    Thyroid; 2018 Apr; 28(4):528-536. PubMed ID: 29589999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of human orbital fibroblasts cultivated from intraconal, nasal and central adipose tissues.
    Kim JA; Ahn D; Kim BY; Choi YJ; Shin HJ; Jang SY
    Br J Ophthalmol; 2021 Feb; 105(2):290-296. PubMed ID: 31488432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.